(Total Views: 364)
Posted On: 06/14/2019 11:33:54 AM
Post# of 154890
I agree. I don't think they intentionally didn't want to provide support to make the TO more successful....i.e. they expected TNBC injection before TO closed, but that obviously didn't happen.
Samsung obviously wants CytoDyn to be successful, so I expect them to infuse cash as some point if some deal is not inked soon. IMO there is no question that they will get Leronlimab to market no later than end of 1Q2020, the questions that remain are at what costs to current shareholders and how what road we travel on to get there (dangerous mountain road, interstate or somewhere in the middle)?
Samsung obviously wants CytoDyn to be successful, so I expect them to infuse cash as some point if some deal is not inked soon. IMO there is no question that they will get Leronlimab to market no later than end of 1Q2020, the questions that remain are at what costs to current shareholders and how what road we travel on to get there (dangerous mountain road, interstate or somewhere in the middle)?
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
